189 results on '"Vizzutti F"'
Search Results
2. OC.11.1: UNDERDILATION STRATEGY FOR TIPS PLACEMENT REDUCES INCIDENCE OF OVERT HEPATIC ENCEPHALOPATHY WITHOUT AFFECTING CLINICAL EFFICACY AND SURVIVAL: RESULTS OF A MULTICENTER PROSPECTIVE ITALIAN STUDY
3. BOC.02.7: UNDERDILATED NEOADJUVANT-TIPS IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION CANDIDATES TO OPERATIVE INTERVENTIONS
4. BOC.02.4: EPISODIC OVERT HEPATIC ENCEPHALOPATHY AFTER TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT DOES NOT INCREASE MORTALITY IN PATIENTS WITH CIRRHOSIS
5. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis
6. Response to “Hepatic encephalopathy and survival after transjugular intra-hepatic portosystemic shunt: do spontaneous portosystemic shunts matter?”
7. Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study
8. Transjugular intra-hepatic portosystemic shunt (TIPS) in elderly patients: preliminary analysis of a multicenter retrospective cohort.
9. Placement of a trans-jugular intrahepatic portosystemic shunt (TIPS) modifies the expression of soluble mediators by circulating monocytes
10. Underdilated neoadjuvant-TIPS in patients with cirrhosis and portal hypertension candidates to operative interventions
11. External Validation of the ExPeCT TIPS Prediction Model in a North American Cohort
12. Underdilation strategy for TIPS placement reduces incidence of overt hepatic encephalopathy without affecting clinical efficacy and survival: results of a multicenter prospective Italian study
13. End-procedural complete haemodynamic response may not be essential for the clinical success of TIPS in patients with cirrhosis
14. Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool?
15. Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis
16. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C
17. Assessment of sarcopenia improves the prediction of post-TIPS mortality in older adult patients with cirrhosis.
18. Effective albumin concentration and albumin function improve after long-term albumin therapy in patients with decompensated cirrhosis
19. Consensus conference on TIPS management: Techniques, indications, contraindications
20. Authors’ reply
21. Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent
22. ADMA correlates with portal pressure in patients with compensated cirrhosis by Vizzutti et al. Eur J Clin Invest 2007; 37: 509–15
23. ADMA correlates with portal pressure in patients with compensated cirrhosis
24. the pathogenesis of fibrosis in non-alcoholic steatohepatitis
25. Update on ascites and hepatorenal syndrome
26. VIATORR stent grafts do not self-expand to their nominal diameters in cirrhotic livers: good news from a computed tomography-based Italian multicentric study
27. Elastography for the non-invasive assessment of liver disease: limitations and future developments
28. Dietary supplementation with olive oil with or without n-3 PUFA differentially affect inflammation and progression of experimental nonalcoholic steatohepatitis
29. Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease
30. Clinical evaluation of disease progression in chronic liver disease: towards an integrated system?
31. Aggressive Gastric Carcinoma Producing Alpha-Fetoprotein: A Case Report and Review of the Literature
32. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C.
33. 1256 DIETARY SUPPLEMENTATION WITH OLIVE OIL WITH OR WITHOUT N-3 PUFA DIFFERENTIALLY AFFECTS INFLAMMATION AND PROGRESSION OF EXPERIMENTAL NONALCOHOLIC STEATOHEPATITIS
34. F-32 Dietary supplementation with olive oil with or without n-3 PUFA differentially affects inflammation and progression of experimental nonalcoholic steatohepatitis
35. 289 THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS
36. Elastography for the non-invasive assessment of liver disease: limitations and future developments
37. Non invasive diagnosis of portal hypertension in cirrhotic patients
38. AMP-activated protein kinase (AMPK) regulates the activation process of hepatic stellate cells
39. Transient elastography (TE) is more effective for the identification of HCV patients with severe (≥F3) rather than significant (≥F2) liver fibrosis
40. 762 TRANSIENT ELASTOGRAPHY (TE) IS MORE EFFECTIVE FOR THE IDENTIFICATION OF HCV PATIENTS WITH ADVANCED (F3-F4) RATHER THAN SIGNIFICANT (F2-F4) LIVER FIBROSIS
41. 462 AMP-ACTIVATED PROTEIN KINASE (AMPK) REGULATES THE ACTIVATION PROCESS OF HEPATIC STELLATE CELLS
42. Response to letter by R. Mookerjee and R. Jalan
43. [713] CURCUMIN INHIBITS THE FIBROGENIC PROGRESSION OF MURINE STEATOHEPATITIS
44. [78] COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSIS
45. [210] EVIDENCE FOR A PATHOGENETIC ROLE OF ASYMMETRIC DIMETHYLARGININE (ADMA) IN CIRRHOTIC PORTAL HYPERTENSION
46. Curcumin inhibits the fibrogenic progression of murine steatohepatitis
47. Liver stiffness measurement (LSM) is able to predict severe portal hypertension in patients with HCV-related advanced chronic liver disease
48. Review article: the pathogenesis of fibrosis in non‐alcoholic steatohepatitis
49. Diuretic and natriuretic effects of long-term albumin infusion in patients with cirrhosis and ascites: a randomised controlled study
50. Hemodynamic, renal and endocrine effects of nitric oxide synthase inhibition in compensated cirrhosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.